The Impact of Sex on the Response to Mesenchymal Stem Cell Therapy in Patients With Non-Ischemic Dilated Cardiomyopathy

被引：0
|
作者：
Florea, Victoria
Rieger, Angela C.
Natsumeda, Makoto
Tompkins, Bryon A.
Banerjee, Monisha
Schulman, Ivonne H.
Landin, Ana M.
Khan, Aisha
Valasaki, Krystalenia
Difede, Darcy L.
Premer, Courtney
Balkan, Wayne
Mitrani, Raul D.
Hare, Joshua M.
机构：
来源：
CIRCULATION | 2017年 / 136卷
关键词：
Cardiomyopathy; Heart failure; Stem cell therapy; Sex differences; Regenerative medicine stem cells;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
14005
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Prognostic predictors of outcomes in patients with non-ischemic dilated cardiomyopathy
    Vaikhanskaya, T.
    Sidorenko, I.
    Gul, L.
    Bogush, Z.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S260 - S260
  • [22] EFFICACY OF CD34+STEM CELL THERAPY IN NON-ISCHEMIC DILATED CARDIOMYOPATHY IS ABSENT IN PATIENTS WITH DIABETES BUT PRESERVED IN PATIENTS WITH INSULIN RESISTANCE
    Vrtovec, Bojan
    Sever, Matjaz
    Jensterle, Mojca
    Poglajen, Gregor
    Janez, Andrej
    Kravos, Nika
    Zemljic, Gregor
    Cukjati, Marko
    Cernelc, Peter
    Haddad, Francois
    Wu, Joseph C.
    Jorde, Ulrich P.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A963 - A963
  • [23] Clinical Outcomes of Autologous Stem Cell Patch Implantation for Heart Failure Patients With Non-ischemic Dilated Cardiomyopathy
    Domae, Keitaro
    Miyagawa, Shigeru
    Toda, Koichi
    Yoshioka, Daisuke
    Kainuma, Satoshi
    Kawamura, Takuji
    Kawamura, Ai
    Kashiyama, Noriyuki
    Iseoka, Hiroko
    Ito, Emiko
    Harada, Akima
    Takeda, Maki
    Yamada, Tomomi
    Sawa, Yoshiki
    CIRCULATION, 2020, 142
  • [24] The efficacy of bone marrow mononuclear stem cell transplantation in patients with non-ischemic dilated cardiomyopathy—a meta analysis
    Nso Nso
    Kaveh Rezaei Bookani
    Sostanie Takota Enoru
    Farshid Radparvar
    Robert Gordon
    Heart Failure Reviews, 2022, 27 : 811 - 820
  • [25] GCSF treatment for non-ischemic dilated cardiomyopathy
    Tomita, S
    CARDIOVASCULAR DRUGS AND THERAPY, 2006, 20 (02) : 83 - 84
  • [26] GCSF Treatment for Non-Ischemic Dilated Cardiomyopathy
    Shinji Tomita
    Cardiovascular Drugs and Therapy, 2006, 20 : 83 - 84
  • [27] Non-ischemic dilated cardiomyopathy and cardiac fibrosis
    Bianca Olivia Cojan-Minzat
    Alexandru Zlibut
    Lucia Agoston-Coldea
    Heart Failure Reviews, 2021, 26 : 1081 - 1101
  • [28] Non-ischemic dilated cardiomyopathy and cardiac fibrosis
    Cojan-Minzat, Bianca Olivia
    Zlibut, Alexandru
    Agoston-Coldea, Lucia
    HEART FAILURE REVIEWS, 2021, 26 (05) : 1081 - 1101
  • [29] Transendocardial Stem Cell Transplantation in Patients with Ischemic vs. Non-Ischemic Cardiomyopathy
    Vrtovec, Bojan
    Poglajen, Gregor
    Lezaic, Luka
    Sever, Matjaz
    Domanovic, Dragoslav
    Cernelc, Peter
    Haddad, Francois
    CIRCULATION, 2012, 126 (21)
  • [30] THE EFFECTS OF CD34+CELL THERAPY ON FUNCTIONAL MITRAL REGURGITATION IN PATIENTS WITH NON-ISCHEMIC DILATED CARDIOMYOPATHY
    Frljak, Sabina
    Zemljic, Gregor
    Poglajen, Gregor
    Cerar, Andraz
    Jaklic, Martina
    Haddad, Francois
    Vrtovec, Bojan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 1010 - 1010
12345